Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAZEMETOSTAT for Follicular lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where TAZEMETOSTAT was used for Follicular lymphoma.

Most Reported Side Effects for TAZEMETOSTAT

Side Effect Reports % Deaths Hosp.
Disease progression 26 26.0% 3 1
Neutropenia 12 12.0% 6 3
Malignant pleural effusion 11 11.0% 0 1
Blood lactate dehydrogenase increased 10 10.0% 0 0
Drug ineffective 10 10.0% 5 3
Lymphadenopathy 10 10.0% 0 0
Off label use 10 10.0% 1 2
Myelodysplastic syndrome 8 8.0% 0 0
Thrombocytopenia 8 8.0% 0 1
Anaemia 7 7.0% 2 1
Fatigue 6 6.0% 0 3
Pneumocystis jirovecii infection 6 6.0% 6 2
Febrile neutropenia 5 5.0% 1 2
Nausea 5 5.0% 1 3
Vomiting 5 5.0% 1 4

Other Indications for TAZEMETOSTAT

Diffuse large b-cell lymphoma (22) Product used for unknown indication (11)

Other Drugs Used for Follicular lymphoma

LENALIDOMIDE (3,611) RITUXIMAB (3,294) OBINUTUZUMAB (2,527) BENDAMUSTINE (1,560) CYCLOPHOSPHAMIDE (1,367) VINCRISTINE (1,224) DOXORUBICIN (1,115) PREDNISONE (889) TAZEMETOSTAT HYDROBROMIDE (439) ETOPOSIDE (352)

Related Pages

TAZEMETOSTAT Full Profile All Follicular lymphoma Drugs TAZEMETOSTAT Demographics TAZEMETOSTAT Timeline